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Although the reduction of serum triacylglycerol concen- 
trations by dietary fish oil is a well-known effect, the ex- 
act mechanism of this effect has not been previously 
studied in human subjects. Therefore, the Aim of this study 
was (i} to examine the effect of short-term fish oil sup- 
plementation on blood concentrations of ketone bodies, free 
fatty acids and triacylglycerol in healthy humans and (ii) 
to verify whether the observed relationships between these 
variables would be consistent with reduced lipolysis andlor 
enhanced hepatic fatty acid oxidation after fish oil sup  
plementation. Twenty subjects {21-23 years, normal fiver 
function tests} were randomly divided into two groups to 
supplement heir usual diet with either 30 g/d of fish oil 
(n = 11) or olive oil {n = 9). Venous blood samples were 
drawn after an overnight fast, before and after 1, 3 and 
7 d of fish oiltolive oil supplementation. Blood concentra- 
tions of triacylglycerol and free fatty acids decreased con- 
sistently after fish oil supplementation; the reduction was 
already significant after one day of fish oil {P < 0.001 for 
triacylglycerol and P = 0.01 for free fatty adds}. In con- 
trast, neither of these blood values changed after olive oil 
supplementation {P > 0.10}. No significant changes in glu- 
cose, insulin or ketone body levels were observed in either 
group after supplementation. After fish oil, but not after 
olive oil supplementation, the ratio of blood ketone body 
levels to free fatty acid levels increased significantly 
(P < 0.05}. Furthermore, after fish oil supplementation 
only, free fatty acid levels were significantly correlated 
with levels of ketone bodies (day 7 of supplementation: r 
= 0.90, P < 0.001) and triacylglycerol (mAxlmum value on 
day 3: r = 0.77, P < 0.01}. These findings suggest that 
reduced lipolysis and increased hepatic fl~xidation/keto- 
genesis may contribute to reduced triacylglycerol evels 
after o~3 fatty acid supplementation i humans. Turnover 
studies are needed in order to further quantitate these 
processes. 
Lipids 29, 41-45 {1994}. 
The o~3 fatty acids eicosapentaenoic acid (EPA) and doc~ 
sahexaenoic a id (DHA) in fish oil have aroused increasing 
interest over the past two decades because of their poten- 
tial role in the prevention and treatment ofcardiovascular 
disease (1,2). One of the well-described effects of r fatty 
acids from fish oil on humans is the reduction of serum 
triacylglycerol concentrations (3-7). The exact mechanism 
of this effect on humans is unknowm Animal studies have 
mainly focused upon the inhibitive ffects of r fatty acids 
on very low density lipoprotein (VLDL) formation and secre 
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tion (8,9), especially triacylglycerol synthesis (10-15). Re- 
cently, it was suggested that a slower formation of plasma 
VLDL triacylglycerols in rats fed fish oil may be due to a 
faster ate of hepatic fatty acid oxidation {16}. There am also 
recent animal data suggesting that w3 fatty acids may 
reduce lipelysis from adipose tissue, thus limiting the availa- 
bility of free fatty acids as a substrate for hepatic triacyl- 
glycerol formation (17,18). 
Although the ultimate goal of animal studies is to gain 
insight into potential mechanisms of the action of r fatty 
acids in humans, no human studies on the effect of r fatty 
acids on lipolysis and ketone body production have been 
reported so far. Therefore, the aim of the present study was 
to investigate he effects of dietary fish oil on blood levels 
of free fatty acids, ketone bodies and triacylglycerol in
healthy human subjects, and to verify whether the observed 
relationships between these variables would be consistent 
with reduced lipolysis and~or enhanced hepatic fatty acid 
oxidation after fish oil supplementation. 
MATERIALS AND METHODS 
Subjects and study design. The study protocol was ap- 
proved by the Research Ethics Committee of the Univer- 
sity Hospital of Rotterdam, and written informed consent 
was obtained from all subjects prior to the study. Eligi- 
ble for the study were healthy medical students aged 
21-23 yr who were on normal, nonslimming diets with, 
at most, one meal of fish per week. All subjects had nor- 
mal liver function tests and took no fish from one week 
prior to the study and throughout. Twenty-two subjects 
were randomly distributed over an experimental nd a 
placebo group in a double-blinded fashion. Two subjects 
from the placebo group did not show up on the first day 
of the study, leaving eleven subjects in the experimental 
group and nine in the placebo group. Subjects in the ex- 
perimental group took 30 g of MaxEPA fish oil per day, 
containing a total of 9 g w3 fatty acids per day (EPA, 5.4 
g/d; DHA, 3.6 g/d) for 7 d. Subjects in the placebo group 
took 30 g of olive oil per day during the same period. Cap- 
sules of fish oil and olive oil (indistinguishable y addi- 
tion of peppermint oil and ferrous oxide coloring} were 
kindly provided by Seven Seas Ltd. (Hull, United 
Kingdom}, and taken as 3 • 10 capsules per day with the 
main meals. 
Measurements. Following an overnight fast of approxi- 
mately 12 h, subjects came to the laboratory between 8
and 9 am., before (day 0) and after supplementation {days 
1, 3 and 7}. On these days, subjects were weighed, and 
venous blood samples were drawn from the forearm. 
Height was measured once preceding the study. 
Laboratory analyses. Glucose concentrations i  whole 
blood were determined by an enzymatic assay using an 
Epos 5060 analyzer (Merck-Eppendorf, Darmstadt, Ger- 
many) with reagents from Boehringer (Mannheim, Ger- 
many). Triacylglycerol in serum was determined en- 
zymatically on a Chem-1 analyzer (Bayer-Technicon, 
Copyright 9 1994 by AOCS Press LIPiDS, Vol. 29, no. 1 (1994) 
42 
P.C. DAGNELIE ET AL. 
Tarrytown, New York). Free fatty  acids were determined 
in ethylenediaminetetraacetic acid-treated plasma using 
an enzymatic olorimetric method (NEFA C test kit; Wako 
Chemicals, Neuss, Germany). A conversion factor of 0.282 
was used (derived from the molecular weight of oleic acid) 
for conversion of these values (from ~nnol/L into rag/L). 
For determination of ketone bodies in whole blood, 4 mL 
of blood was poured immediately into a glass bottle con- 
taining 4 mL ice-cold perchloric acid, and, after neutraliza- 
tion with KOH (19), stored at -20~ until the study was 
completed. Acetoacetate and ~-hydroxybutyrate concen- 
trations were determined according to Mellanby and 
Williamson (19) and WiUiamson and Mellanby (20), respec- 
tively. Insulin in serum was determined using a commeP 
cial radioimmunoassay test kit {Medgenix, Brussels, 
Belgium). 
Compliance. For each subject, the number of capsules 
taken per day was calculated by pre- and post-weighing 
supplied capsules, and used as an indicator of compliance 
Statistical analysis. Blood values are expressed as 
means _+ SEM, except for free fatty acids, ketone bodies 
and the ketone body/free fatty acid ratio. As the latter 
showed a skewed istribution which best fitted normal dis- 
tr ibution after log-transformation, log-transformed data 
were used for statistical calculations of these parameters, 
and data for these parameters are presented as geometri- 
cal means and range Changes in blood values within one 
group were tested for statistical significance using Stu- 
dent's paired t-test. Comparison of the effects of fish oil 
vs. olive oil supplementation blood values was tested 
after adjustment for baseline values by analysis of covari- 
ance. Mean values and 1, 3 and 7 d of supplementation 
were used for the previously mentioned statistical calcula- 
tions. For comparing residual variances between groups, 
the standard F-test was used {21). Changes in residual 
standard deviation after supplementation within one 
group were tested by 11 "repeated measurements analysis 
of variance" using module 5V of BMDP (22). P values less 
than 0.05 were considered statistically significant. 
RESULTS 
Anthropometric measurements. Baseline values of body 
weight and height were similar in the fish oil group and 
the olive oil group. The quetelet index was 21.7 ___ 0.6 
kg/cm 2 (mean + SEM) in the fish oil group and 22.5 ___ 
1.3 kg/cm 2 in the olive oil group. No relation between 
quetelet index and baseline values of any of the measured 
blood parameters was detected. No significant changes 
in weight were observed in either group during the 
study (fish oil group, 0.2 ___ 0.1 kg;, olive oil group, -0 .5  
+_ O.3 kg). 
Compliance. Participants had been instructed to take 
30 g of the provided supplement per day. The estimated 
"actual" intake ranged from 29-31 g/d in the fish oil group 
and from 29-32 g in the olive oil group, indicating good 
compliance 
Blood values. Blood glucose and insulin concentrations 
did not change systematical ly after fish or olive oil sup- 
plementation (Table 1). Triacylglycerol concentrations de- 
creased by 24% (P < 0.001) within I d of fish oil supple- 
mentation. After 7 d of fish oil supplementation, tri- 
acylglycerol had decreased by 46% (P < 0.001), as com- 
pared to baseline (Table 1). Olive oil supplementation had 
no significant effect on triacylglycerol levels (P > 0.10; 
Table 1). The effects of fish oil and olive oil supplementa- 
tion on triacylglycerol levels were significantly different 
(P = 0.001). 
Free fatty  acid concentrations decreased by 39% (P = 
0.01) within i d of fish oil supplementation a d remained 
significantly depressed at 3 and 7 d of supplementation 
for each (P < 0.05 as compared to baseline; Table 2). In 
contrast, no significant change in free fatty acid levels was 
observed after olive oil supplementation (P > 0.10). The 
effects of fish oil and olive oil supplementation free 
fatty  acid levels were significantly different (P = 0.03). 
No significant changes in ketone body levels were ob- 
served after either fish oil or olive oil supplementation 
{P > 0.10; Table 2). 
TABLE 1 
Blood Values of Glucose, Insulin and Triacylglyeerol in Healthy Human Subjects Before and After Dietary Supplementation with Fish 
Oil or Olive Oil a 
After supplementation f r P value 
Before Change within Change compared 
supplementation 1 d 3 d 7 d groups b between groups c 
Glucose (retool/L) 
Fish oil group 4.2 + 0.1 4.3 _ 0.1 4.3 _ 0.1 4.0 + 0.1 NS d NS 
Olive oil group 4.4 +- 0.2 4.6 _ 0.2 4.3 +. 0.1 4.3 +_ 0.1 NS 
Insulin (pmol/L) 
Fish oil group 102 +. 9 104 +_ 11 84 +. 10 97 +. 13 NS NS 
Olive oil group 121 +, 12 97 + 10 92 +. 9 99 +. 9 NS 
Triacylglycerol (mmol/L) 
Fish oil group 0.96 +_ 0.08 0.73 __. 0.06 0.64 +. 0.05 0.61 + 0.06 < 0.001 0.001 
Olive oil group 1.04 +. 0.17 0.98 +. 0.13 1.04 +. 0.10 1.07 +. 0.14 NS 
aHealthy human subjects were randomized to take a daily supplement ofeither 30 g fish oil (9 g o~3 fatty acids; n = 11) or 30 g olive 
oil {n = 9) for 7 d. Each figure represents he arithmetic mean + SEM. 
bpaired t-test {mean value of 1, 3 and 7 d of supplementation vs.baseline value). 
CEffects of fish oil vs. olive oil supplementation were tested using mean values of 1, 3 and 7 d of supplementation, adjusting for baseline 
values by analysis of covariance. 
dNS, not significant. 
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TABLE 2 
Blood Values of Free Fatty Acids and Ketone Bodies in Healthy Human Subjects Before and After Dietary Supplementation with Fish 
Oil or Olive Oil a 
Before After supplementation for P value 
supplementation 1 d 3 d 7 d Change within Change compared 
GM (range) GM (range) GM (range) GM (range) groups b between groups c 
Free fatty acids {mg/L) 
Fish oil group 92 (54-141) 56 (35-91) 57 (25-128) 58 (28-195) 0.02 0.03 
Olive oil group 99 (37-236) 84 (18-183) 89 (50-160) 93 (45-158) NS d 
Ketone bodies (~mol/L) 
Fish oil group 46 (27-137) 38 (24-61) 39 (23-58) 42 (22-135) NS NS 
Olive oil group 73 (31-267) 56 (31-III) 58 (30-247) 57 (38-97) NS 
aStudy design: see footnote a to Table 1. Each figure represents he geometrical mean (GM) and range. 
bpaired t-test (mean value of 1, 3 and 7 d of supplementation vs .  baseline value). 
CEffects of fish oil vs .  olive oil supplementation were tested using mean values of 1, 3 and 7 d of supplementation, adjusting for baseline 
values by analysis of covariance. 
dNS, not significant. 
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FIG. 1. Ratios of blood ketone body concentrations to plasma free 
fatty acids before and after 1, 3 and 7 d of fish oil or olive oil sup- 
plementation. Healthy human subjects took a daily supplement of 
either 30 g fish oil (9 g o~3 fatty acids; n = 11) or 30 g olive oil (n 
= 9). Boxes and bars represent means and SEM, respectively, of
logarithmic values (expressed as a percentage of values before sup- 
plementation). Significance of change after fish oil supplementation 
(paired t-test of mean value of l, 3 and 7 d of supplementation vs. 
baseline value), P < 0.05; olive oil supplementation, P > 0.10. Com- 
parison of the effects of fish oil vs .  olive oil supplementation (mean 
values of 1, 3 and 7 d of supplementation, adjusting for baseline 
values by analysis of covariance), P = 0.02. 
Ratios of ketone body levels relative to free fatty acid 
levels {Fig. 1) increased significantly after fish oil sup- 
plementation {P < 0.05), but did not change after olive oil 
supplementation (P > 0.10). Again, the effects of fish oil 
and olive oil supplementation were significantly different 
(t' = 0.02). 
In Figure 2, ketone bodies are plotted as a function of 
free fatty acids before and after seven days of supplemen- 
tation with fish off or olive oil. No significant correlation 
between free fatty acid levels and ketone body concentra- 
tions was observed in either group before supplementa- 
tion, or after olive oil supplementation (P > 0.10). In con- 
trast, these two parameters were highly correlated after 
seven days of fish oil supplementation (r = 0.90, 
P < 0.001). The residual standard deviation of blood 
ketone body levels against free fatty acid levels was con- 
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FIG. 2. Blood ketone body concentrations {/~mol/L) as a function of 
plasma free fatty acid concentrations banol/L) before and after sup- 
plementation with fish or olive oil; (A) before fish oil supplementa- 
tion, (B) after 7 d of fish oil supplementation, (C) before olive oil sup- 
plementation, (D) after 7 d of olive oil supplementation. The methods 
used are those given in the caption for Figure 1. 
sistently reduced after seven days of fish oil supplemen- 
tation (P ~ 0.01), and residual standard deviation was 
significantly lower after fish oil supplementation than 
after olive oil supplementation {day 7: P < 0.001). As the 
total variation in ketone body levels did not increase after 
fish oil supplementation {Table 2 and Fig. 2), the increase 
in correlation between free fatty acid and ketone body 
levels after fish oil supplementation (and the difference 
in correlation when compared with olive oil supplementa- 
tion) was exclusively attributed to a reduction in residual 
standard deviation after fish oil supplementation. 
Free fatty acid levels were not significantly correlated 
with triacylglycerol concentrations in either group before 
supplementation or after olive oil supplementation 
(P > 0.10). An increased correlation was observed after 
seven days of fish oil supplementation which, however, did 
not reach statistical significance {r --- 0.52; P = 0.10). 
After three days of fish oil supplementation, the correla- 
tion between free fatty acid and triacylglycerol levels was 
highly significant (r = 0.77, P < 0.01). 
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DISCUSSION 
Although it is well known that marine 0)3 fatty acids 
reduce serum triacylglycerol concentrations in humans 
(3-7), the mechanism underlying this effect is not 
completely understood. Most of the effects described so 
far, observed in animal models in vivo and in vitro, were 
related to reduced production and secretion of triacylgly- 
cerol-rich lipoproteins (VLDL) by the liver. Effects of 0)3 
fatty acids on nearly every major pathway of hepatic fatty 
acid metabolism have been demonstrated. Reduction of 
triacylglycerol synthesis by 0)3 fatty acids has been at- 
tributed to reduced activities of phosphatidate phospho- 
hydrolase (10,11) and acyl-coenzyme A: 1,2-diacylglycerol 
acyltransferase (12,23), and to a diversion toward phospho- 
lipid synthesis (13-15,24). At high dosage of 0)3 acids, an 
inhibition of VLDL assembly and/or secretion has been 
reported (9). 
A number of animal studies have also demonstrated in- 
creased hepatic p-oxidation capacity and ketone body pro- 
duction after fish oil feeding (11,24-30). Surette t  al. (31) 
observed an increased activity of hepatic arnitine palm- 
itoyltransferase (CPT) in fish oil-fed Syrian hamsters, 
which was highly correlated (r = -0.97) with the diet- 
induced change in serum triacylglycerol levels. Wong et 
al. (25) observed a decreased sensitivity of mitochondrial 
CPT to inhibition by malonyl-CoA. 
Recently, attention has been drawn to the possibility 
that fish oil decreases peripheral lipolysis from adipose 
tissue, thereby reducing the availability of substrate for 
triacylglycerol synthesis in the liver (17,18,27). The ac- 
tivities of lipoprotein lipase and hepatic lipase, enzymes 
which are involved in VLDL catabolism, are unaffected 
by fish oil supplementation (6). 
Because there is little information about hese processes 
in humans, arandomized, placebo-controlled study on the 
effects of fish oil supplementation on blood values of free 
fatty acids, ketone bodies and triacylglycerol, and the rela- 
tionship between these blood values was carried out. Re- 
sults demonstrate that fish oil supplementation nduced 
a rapid parallel reduction in blood concentrations of tri- 
acylglycerol and free fatty acids, whereas ketone body 
levels remained constant. Changing blood values were not 
due to increased fat consumption per se, because sup- 
plementation with placebo (olive oil) did not affect either 
free fatty acid or triacylglycerol levels. 
Although the reduction i  free fatty acid levels after fish 
oil supplementation has not been systematically studied 
in healthy human subjects, Singer et at  (17) recently 
reported that dietary supplementation with 0)3 fatty acids 
resulted in a marked ecrease in free fatty acid levels dur- 
ing a standard glucose tolerance test in hyperlipidemic 
patients. Otto et al. (18) observed a dose-dependent reduc- 
tion in plasma free fatty acids by 0)3 fatty acids in rats 
fed ad l ibitum, but not in rats fasted overnight. Since in- 
sulin concentration were constant and glucose concentra- 
tions increased, the authors (18) concluded that lower 
plasma free fatty acid levels could not be explained by 
either increased insulin concentrations or improved insulin 
sensitivity of adipose tissue. Preliminary data from 
another recent study (32) in rats fed marine 0)3 fatty acids 
confirmed a marked reduction i  free fatty acid levels. In 
addition, a significant reduction of fatty acid mobiliza- 
tion from epididymal dipocytes ofthese rats was demon- 
strated (32). Our finding of reduced blood values of free 
fatty acids in spite of constant glucose and insulin levels 
after fish oil supplementation s consistent with these re- 
cent reports. 
In their studies with rats, Otto et al. (18) observed a
positive correlation (r= 0.71) between blood values of free 
fatty acids and triacylglycerol. A similar correlation (r= 
0.77) was observed in the present study after three days 
of fish oil supplementation. This would suggest that the 
lowering of plasma free fatty acids by dietary fish oil may 
have contributed tothe decrease inserum triacylglycerol 
levels. 
In spite of the decrease in plasma free fatty acid levels 
after fish oil supplementation, we did not detect any signi- 
ficant changes in blood ketone body levels. As a conse- 
quence, the ratio of ketone bodies to free fatty acids in- 
creased significantly after fish oil supplementation. It is 
unlikely that this was caused by decreasing ketone body 
removal from the blood, as ketone body uptake by peri- 
pheral tissues is thought o be controlled by the ketone 
body concentrations presented to them (33,34). Arterial 
ketone body levels closely reflect hepatic ketone body pr~ 
duction (35). Therefore, the increased ratio of ketone bodies 
to free fatty acids, combined with the markedly high cor- 
relation (r -- 0.90) between these blood values after fish 
oil supplementation, suggests an increased capacity for 
fatty acid oxidation and/or ketogenesis in the liver. This 
suggestion is consistent with animal studies that 
demonstrated increased/3-oxidation and ketogenesis by 
dietary 0)3 fatty acids (11,24-31). 
If increased hepatic/3-oxidation and ketogenesis would 
not be counteracted by reduced lipolysis from adipose 
tissue, ketosis would occur (36). It is speculated that the 
combination ofdecreased lipolysis and increased capacity 
or hepatic fl.oxidation/ketogenesis may be a concerted 
mechanism whereby fish oil reduces triacylglycerol for- 
mation in the liver without, however, simultaneously in-
ducing ketosis. 
In conclusion, our study shows that dietary fish oil, in 
addition to its well-known effect of reducing serum tri- 
acylglycerol concentrations, induces arapid reduction in 
blood free fatty acids, and a parallel rise in the ratio of 
ketone bodies relative to free fatty acids. These effects ap- 
pear not to be due to changes in insulin concentration r 
sensitivity, and because they occur within one day of sup- 
plementation, they are unlikely to be related to altered 
membrane composition by 0)3 fatty acids. Our findings 
are consistent with the notion that reduced lipolysis and 
increased hepatic/3-oxidation]ketogenesis may contribute 
to reduced triacylglycerol levels after w3 fatty acid sup- 
plementation i humans. Turnover studies are needed 
in order to provide further quantitation of these pro- 
cesses. 
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